VYCO OTC
Vycor Medical, Inc.
1W: +0.0%
1M: +0.0%
3M: +5.6%
YTD: -44.6%
1Y: -61.7%
3Y: -28.0%
5Y: -66.2%
$0.07
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$2M
+17.2% ▲
5Y CAGR: +10.3%
Gross Profit
$2M
+9.7% ▲
5Y CAGR: +9.1%
Operating Income
$34K
+470.7% ▲
Net Income
-$72K
+32.4% ▲
EPS (Diluted)
$-0.00
+33.3% ▲
EBITDA
-$61K
-200.7% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $1M | $1M | $1M | $2M | $2M |
| YoY Growth | +22.0% | -12.2% | +19.4% | +8.8% | +17.2% |
| Cost of Revenue | $135K | $141K | $145K | $167K | $302K |
| Gross Profit | $1M | $1M | $1M | $1M | $2M |
| Gross Margin | 90.3% | 88.5% | 90.1% | 89.5% | 83.8% |
| R&D Expenses | $15K | $0 | $23K | $15K | $10K |
| SG&A Expenses | $2M | $1M | $1M | $1M | $1M |
| Operating Expenses | $2M | $1M | $1M | $1M | $1M |
| Operating Income | -$436K | -$307K | $40K | -$9K | $34K |
| Operating Margin | -31.3% | -25.1% | 2.8% | -0.6% | 1.8% |
| Interest Expense | $88K | $92K | $103K | $104K | -$50K |
| Income Before Tax | -$408K | -$400K | -$63K | -$107K | -$70K |
| Tax Expense | $0 | $0 | $0 | $0 | $2K |
| Net Income | -$523K | -$406K | -$70K | -$107K | -$72K |
| Net Margin | -37.6% | -33.2% | -4.8% | -6.7% | -3.9% |
| EPS (Diluted) | $-0.02 | $-0.01 | $-0.01 | $-0.00 | $-0.00 |
| EBITDA | -$252K | -$246K | $101K | $61K | -$61K |
| Shares Outstanding | 30M | 32M | 33M | 33M | 33M |